Do elevated fecal secretory IgA and stool inflammation markers indicate active mucosal immune engagement without overt bleeding or neutrophilic inflammation?

When assessing gastrointestinal symptoms, distinguishing between localized, protective mucosal immune activation and overt, tissue-destructive inflammation is crucial for guiding clinical decisions.

Clinical evidence

• Exceptional negative predictive value: Normal levels of fecal calprotectin (<50 µg/g) paired with negative fecal lactoferrin demonstrate a negative predictive value (NPV) ranging from 93% to over 99% for excluding active inflammatory bowel disease (IBD) and organic colitis.
• Consolidated assessment of bleeding and injury: Although microscopic stool white blood cells (WBCs) and fecal occult blood are insensitive as standalone markers, their combined absence alongside normal calprotectin and lactoferrin strongly rules out active mucosal injury and overt neutrophilic infiltration, allowing clinicians to confidently rule out active bleeding.

Mechanistic explanations

• Adaptive barrier defense: Secretory IgA (sIgA) is the primary immunological defense molecule at the mucosal interface. Elevated fecal sIgA directly indicates active mucosal immune engagement and adaptive humoral defense, which upregulates in response to luminal challenges, dysbiosis, or increased epithelial barrier stress.
• Immune exclusion and regulation: Mechanistically, active mucosal engagement via sIgA promotes immune exclusion and oral tolerance. This pathway serves to neutralize luminal antigens and limit pathogen penetration, thereby modulating and actively limiting tissue-destructive neutrophilic cascades and subsequent mucosal bleeding.
• Localized inflammatory signaling: Co-elevation of sIgA and stool inflammatory markers represents active mucosal immune engagement, signifying that both adaptive barrier defense and localized innate pathways are actively mobilized to manage barrier stress.

Bottom line

• Normal calprotectin (<50 µg/g), negative lactoferrin, negative occult blood, and absent stool WBCs collectively rule out overt neutrophilic inflammation or active bleeding with up to 99% certainty, while elevated sIgA and stool inflammation markers indicate localized, protective mucosal immune engagement reacting to barrier stress.